[Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
Shindo
Michiko
M
Division of Liver Diseases, Akashi Municipal Hospital.
Okuno
Tadao
T
D000998:Antiviral Agents / Q000627:therapeutic use; D002353:Carrier State / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008099:Liver / Q000473:pathology*; D012367:RNA, Viral / Q000032:analysis; D012254:Ribavirin / Q000627:therapeutic use; D013997:Time Factors; D014764:Viral Proteins / Q000235:genetics
D000998:Antiviral Agents; C400562:HVR1 protein, Hepatitis C virus; D012367:RNA, Viral; D014764:Viral Proteins; D012254:Ribavirin; D007372:Interferons